
More shares, more cash
AXT said the underwriters in its recently completed public offering exercised their over-allotment option, buying an extra 1,284,046 shares of common stock at $64.25 apiece. That works out to roughly $82.5 million in additional gross proceeds.
Why you should care
This is basically the stock market version of saying, “Hey, while you’re here, want a little more?” The company gets more capital, which can be helpful if it wants to shore up the balance sheet or fund growth. But every new share also chips away at existing holders’ slice of the pie.
Dilution, meet reality
Investors already had one eye on AXT after the original offering. Now the greenshoe exercise adds another layer of dilution, which is great if you’re the company treasury and less great if you were hoping your ownership percentage would stay put.
Big picture
For AXT, the upside is a bigger cash cushion. For shareholders, the tradeoff is simple: more financial flexibility today, but a thinner claim on tomorrow’s earnings. And in a market that already gets twitchy about equity raises, that’s not exactly a party invite.
